The macrophage – a novel system to deliver gene therapy to pathological hypoxia
暂无分享,去创建一个
A. Harris | P. Ratcliffe | C. Lewis | P. Maxwell | S. Kingsman | C. Lewis | P Ratcliffe | S. Naylor | K. Binley | S. Iqball | L Griffiths | K Binley | S Iqball | O Kan | P Maxwell | C Lewis | A Harris | S Kingsman | S Naylor | O. Kan | A. Harris | P. Maxwell | L. Griffiths
[1] B. Ebert,et al. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[2] G. Melillo,et al. Functional Requirement of the Hypoxia-responsive Element in the Activation of the Inducible Nitric Oxide Synthase Promoter by the Iron Chelator Desferrioxamine* , 1997, The Journal of Biological Chemistry.
[3] T. K. Hunt,et al. Oxygen tension regulates the expression of angiogenesis factor by macrophages. , 1983, Science.
[4] F. Balkwill,et al. Hypoxia down‐regulates MCP‐1 expression: implications for macrophage distribution in tumors , 1998, Journal of leukocyte biology.
[5] G. Dachs. Targetting gene expression of hypoxic cells , 1997 .
[6] J. Knisely,et al. Hypoxia and angiogenesis in experimental tumor models: therapeutic implications. , 1997, EXS.
[7] M. Gassmann,et al. Oxygen(es) and the hypoxia-inducible factor-1. , 1997, Biological chemistry.
[8] F. Gage,et al. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.
[9] D. Curiel,et al. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high‐efficiency stable transduction in vivo , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] P. Ratcliffe,et al. Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Sutherland. Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.
[12] L. Enquist,et al. Protocols for gene transfer in neuroscience : towards gene therapy of neurological disorders , 1996 .
[13] S. McKnight,et al. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. , 1997, Genes & development.
[14] C. Scheibenbogen,et al. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. , 1990, Cancer research.
[15] A. Kingsman,et al. An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer , 1999, Gene Therapy.
[16] P. Polverini. Role of the macrophage in angiogenesis-dependent diseases. , 1997, EXS.
[17] J. Albina,et al. Macrophage activation by culture in an anoxic environment. , 1995, Journal of immunology.
[18] I. Kovesdi,et al. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. , 1995, Gene therapy.
[19] T. Gatanaga,et al. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. , 1993, The Journal of surgical research.
[20] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[21] R. Andreesen,et al. Adoptive immunotherapy of cancer using monocyte‐derived macrophages: rationale, current status, and perspectives , 1998, Journal of leukocyte biology.
[22] A. Harris,et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.
[23] A. Harris,et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. , 1998, Blood.
[24] D. Waxman,et al. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy. , 1998, Cancer research.